Physician profile
Hershel Bhadsavle
NPI 1568881639
$7,955.31
in general payments reported to CMS, 2019-2025
31 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what 85% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $57.88 · 2021: $170 · 2022: $1,613 · 2023: $2,838 · 2024: $1,372 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,035 · Travel and Lodging: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,034.83 |
| Travel and Lodging | $962.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,729.73 | 2022-2025 | Illumisite |
| Glaxosmithkline, LLC. | $934.64 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $895.21 | 2021-2025 | Ofev, Jascayd |
| Grifols USA, LLC | $628.92 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Astrazeneca Pharmaceuticals Lp | $431.01 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $401.25 | 2022-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $344.74 | 2024-2025 | Dupixent |
| Mylan Specialty L.P. | $310.38 | 2019-2024 | Yupelri |
| Baxter Healthcare | $223.91 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $162.93 | 2021-2025 | |
| Verona Pharma, INC. | $104.96 | 2025 | Ohtuvayre |
| Body Vision Medical INC. | $96.85 | 2023 | Lungvision |
| Viatris Specialty LLC | $90.91 | 2025 | Yupelri |
| 3b Medical, INC. | $79.48 | 2025 | Luna |
| Insmed, INC. | $66.33 | 2022-2025 | Brinsupri, Arikayce |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $52.73 | 2024-2025 | |
| Fisher & Paykel Healthcare INC | $51.87 | 2023-2025 | Fisher & Paykel Healthcare |
| Novartis Pharmaceuticals Corporation | $35.56 | 2021 | |
| Merck Sharp & Dohme LLC | $34.90 | 2019 | |
| Jazz Pharmaceuticals INC. | $32.93 | 2019-2020 | |
| Resmed Corp | $32.23 | 2023-2024 | |
| Abbvie INC. | $30.74 | 2023-2024 | Teflaro |
| Portola Pharmaceuticals, LLC | $28.59 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $27.33 | 2024 | Giapreza |
| Olympus America INC. | $26.31 | 2022 | |
| Ambu INC. | $23.03 | 2025 | |
| Acacia Pharma INC | $18.33 | 2022 | |
| Advanced Respiratory, INC | $17.41 | 2021 | |
| Amgen INC. | $17.11 | 2025 | Tezspire |
| Idorsia Pharmaceuticals US INC | $14.09 | 2023 | Quviviq |
| Breas Medical, INC. | $10.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hershel Bhadsavle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.